Johnson & Johnson (JNJ: 63.92 ,-0.39 ,-0.61%) said it's in discussions with the government to resolve a long-running investigation of whether it improperly marketed the antipsychotic Risperdal.
"Discussions are ongoing in an effort to resolve potential criminal and civil litigation arising from these matters," J&J disclosed in a regulatory filing Wednesday. "Whether a resolution can be reached and on what terms is uncertain."
via foxbusiness.com
No comments:
Post a Comment